In NSTEMI, what is the initial management priority in the ED?

Prepare for the Emergency Nursing Orientation 3.0 Cardiovascular Emergencies Test. Use interactive flashcards and detailed explanations with multiple choice questions. Enhance your understanding of cardiovascular emergencies and succeed on your exam!

Multiple Choice

In NSTEMI, what is the initial management priority in the ED?

In NSTEMI, the first priority in the ED is to rapidly risk-stratify the patient and start therapies that reduce myocardial ischemia and thrombosis, with a plan for prompt invasive evaluation if they are high risk. This means assessing risk using scoring tools (like GRACE or TIMI) to determine who needs urgent reperfusion and who can be managed medically. Simultaneously, begin anti-ischemic and antithrombotic treatment: administer aspirin (unless contraindicated) to inhibit platelets, start anticoagulation, and provide dual antiplatelet therapy with a P2Y12 inhibitor as appropriate; give nitrates for chest pain and blood pressure support if needed, and add beta-blockers when not contraindicated to reduce oxygen demand. The goal is to stabilize the patient, limit infarct size, and prepare for coronary angiography/PCI promptly in those at high risk. Thrombolysis is not used for NSTEMI because it offers less benefit and carries more bleeding risk; it’s reserved for STEMI. Observation or treating with nitrates alone does not address the underlying thrombosis and risk, so they’re not adequate by themselves.

In NSTEMI, the first priority in the ED is to rapidly risk-stratify the patient and start therapies that reduce myocardial ischemia and thrombosis, with a plan for prompt invasive evaluation if they are high risk. This means assessing risk using scoring tools (like GRACE or TIMI) to determine who needs urgent reperfusion and who can be managed medically. Simultaneously, begin anti-ischemic and antithrombotic treatment: administer aspirin (unless contraindicated) to inhibit platelets, start anticoagulation, and provide dual antiplatelet therapy with a P2Y12 inhibitor as appropriate; give nitrates for chest pain and blood pressure support if needed, and add beta-blockers when not contraindicated to reduce oxygen demand. The goal is to stabilize the patient, limit infarct size, and prepare for coronary angiography/PCI promptly in those at high risk. Thrombolysis is not used for NSTEMI because it offers less benefit and carries more bleeding risk; it’s reserved for STEMI. Observation or treating with nitrates alone does not address the underlying thrombosis and risk, so they’re not adequate by themselves.

More practice questions